Preclinical antitoxic properties of Spirulina (Arthrospira)

Research output: Contribution to journalScientific reviewpeer-review

6 Scopus citations

Abstract

© 2015 Informa UK Limited, trading as Taylor & Francis Group. Abstract: Context: Spirulina (Arthrospira) exerts a wide spectrum of pharmacological activities which are mainly attributed to its antioxidant effect. However, Spirulina has also been reported (both in preclinical and in clinical scenarios) to exhibit other bioactive effects, including an antitoxic potential. Objective: We performed a systematic review of the literature, conducted in TOXNET, PubMed/MEDLINE, and Science Direct-Scopus; all available years were included. Searching criteria included the effects of Spirulina on experimental poisonings from arsenic, cadmium, carbon tetrachloride, deltamethrin, fluoride, hexachlorocyclohexane, iron, lead, lindane, and mercury. Results: In all cases, it was established that the blue-green alga, and its isolated compounds, effectively counteracted these pollutants toxic effects on the exposed organisms. Some molecular mechanisms are proposed, although they have not been fully elucidated yet. Conclusion: Spirulina could be a useful coadjuvant agent within clinical practice for treatment of these or other pollutants poisonings.
Original languageAmerican English
Pages (from-to)1345-1353
Number of pages1209
JournalPharmaceutical Biology
DOIs
StatePublished - 2 Aug 2016

Fingerprint Dive into the research topics of 'Preclinical antitoxic properties of Spirulina (Arthrospira)'. Together they form a unique fingerprint.

Cite this